[1] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版).肝脏,2011,16:2-16.
[2] 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案.中华传染病杂志,2001,19:56-62.
[3] Liaw YF, Chu CM.Hepatitis B virus infection.Lancet,2009,373:582-592.
[4] Fattovich G, Bortolotti F, Donato F.Natural history of chronic hepatitis B:special emphasis on disease progression and prognostic factors.J Hepatol,2008,48:335-352.
[5] Lin B,Ha NB,Liu A,et al.Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice.J Gastroenterol Hepatol,2013,28:855-860.
[6] Svicher V, Cento V, Salpini R, et al.Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development. Dig Liver Dis, 2011, 43:975-983.
[7] Chang TT, Liaw YF, Wu SS, et al.Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology, 2010, 52:886-893. |
